Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Holger Stammer"'
Autor:
Olga Holubovska, Pavlo Babich, Alla Mironenko, Jens Milde, Yuriy Lebed, Holger Stammer, Lutz Mueller, Aartjan J. W. te Velthuis, Victor Margitich, Andrew Goy
Publikováno v:
Advances in Respiratory Medicine, Vol 92, Iss 3, Pp 202-217 (2024)
Enisamium is an orally available therapeutic that inhibits influenza A virus and SARS-CoV-2 replication. We evaluated the clinical efficacy of enisamium treatment combined with standard care in adult, hospitalized patients with moderate COVID-19 requ
Externí odkaz:
https://doaj.org/article/202cc218d64f4e9fb9263966c5a3df1f
Publikováno v:
Consilium Medicum, Vol 24, Iss 3, Pp 186-192 (2022)
Aim. The pooled efficacy data of two similar randomized placebo-controlled clinical trials were analyzed. Safety was evaluated on the basis of the individual trials. Materials and methods. The efficacy analysis was based on 589 patients. Treatme
Externí odkaz:
https://doaj.org/article/ba80a658b06d4e259329bbf0889e18ff
Autor:
Oliver Pfaar, Achim G. Beule, Detmar Jobst, Karin Kraft, Holger Stammer, Kristina I.L. Röschmann‐Doose, Thomas Wittig, Boris A. Stuck
Publikováno v:
The LaryngoscopeBIBLIOGRAPHY.
ELOM-080 is a phytomedicine approved for the treatment of acute and chronic inflammatory diseases of the respiratory tract, sinusitis, and bronchitis in particular. This prospective, randomized, placebo-controlled, double-blind clinical trial was con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::549e4f0eb98ce9a5cc5b5f3d1e5d34dd
https://pubmed.ncbi.nlm.nih.gov/36222438
https://pubmed.ncbi.nlm.nih.gov/36222438
Autor:
Frederico Sala, Cesare Cosentino, Olha Holubovska, Miguel Muzzio, Jindrich Cinatl, Victor Margitich, David Boltz, Aartjan J. W. te Velthuis, Lutz Mueller, Yuriy Lebed, Denisa Bojkova, Stefano Elli, Xinjian Peng, Holger Stammer, Alla Mironenko, Marco Guerrini, Jens Milde, Andrew Goy, Marco Bechtel
Publikováno v:
Biomedicines
medRxiv
article-version (status) pre
article-version (number) 1
medRxiv
article-version (status) pre
article-version (number) 1
Pandemic SARS-CoV-2 causes a mild to severe respiratory disease called Coronavirus Disease 2019 (COVID-19). Control of SARS-CoV-2 spread will depend on vaccine-induced or naturally acquired protective herd immunity. Until then, antiviral strategies a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ed77d3f92e3dc8c3d484bdad7a97e0e
https://doi.org/10.1101/2021.01.05.21249237
https://doi.org/10.1101/2021.01.05.21249237
Autor:
Lutz Müller, Tatiana G. Zubkova, Holger Stammer, Victor Margitich, Andrew Mehle, Megan Shaw, Aartjan J. W. te Velthuis, David Boltz, Norbert Gmeinwieser, Jens Milde
Publikováno v:
Antimicrobial Agents and Chemotherapy
Infections with respiratory viruses constitute a huge burden on our health and economy. Antivirals against some respiratory viruses are available, but further options are urgently needed. Enisamium iodide (laboratory code FAV00A, trade name Amizon) i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1a77a641742922bbdf653b34ee215b3
https://doi.org/10.1101/2020.12.23.20247569
https://doi.org/10.1101/2020.12.23.20247569
Publikováno v:
Archives of Gynecology and Obstetrics. 304:419-419
A correction to this paper has been published: https://doi.org/10.1007/s00404-021-06093-9
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a38b117c8dcafb55a4ec5321e427d4ac
https://doi.org/10.1007/s00404-021-06093-9
https://doi.org/10.1007/s00404-021-06093-9
Publikováno v:
International journal of clinical practice. 72(12)
OBJECTIVE The aim of this multi-centre, randomised, double-blind, placebo-controlled trial was to compare the efficacy and safety of the fixed combination of 0.5 mg tyrothricin, 1.0 mg benzalkonium chloride, and 1.5 mg benzocaine (study drug marketed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dba3bf35023c7356a543cf3830ca44d9
https://pubmed.ncbi.nlm.nih.gov/31633267
https://pubmed.ncbi.nlm.nih.gov/31633267
Publikováno v:
MMW - Fortschritte der Medizin. 157:6-11
Die akute Rhinosinusitis ist eine haufige entzundliche Erkrankung der Nasen- und Nasennebenhohlenschleimhaut, die mit einer erheblichen Morbiditat und soziookonomischen Belastung verbunden ist. Ein neues Phytotherapeutikum auf Basis eines Trockenextr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1cce1a6420e768aa3a2956fb56affa0d
https://doi.org/10.1007/s15006-015-2934-4
https://doi.org/10.1007/s15006-015-2934-4
Publikováno v:
ACTA OTO-LARYNGOLOGICA
Acta Oto-Laryngologica
Acta Oto-Laryngologica
Objectives: The pooled efficacy data of two similar randomized placebo-controlled clinical trials were analyzed. Safety was evaluated on the basis of the individual trials. Methods: The efficacy analysis was based on 589 patients. Treatment was perfo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f06e46bd4cc3e6e29f1552fca7fd5db3
https://doi.org/10.3109/00016489.2014.952047
https://doi.org/10.3109/00016489.2014.952047
Publikováno v:
Arzneimittelforschung. 56:652-660
Study objective: To assess the efficacy and tolerability of a fixed fluid extract combination of thyme and ivy leaves (thymeivy combination) and matched placebo in patients suffering from acute bronchitis with productive cough. Methods: In a double-b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9fbf02f6aaf68e659316586d0e986911
https://doi.org/10.1055/s-0031-1296767
https://doi.org/10.1055/s-0031-1296767